Innovative Targeting Strategies in Breast Cancer Therapy
Editat de Pankaj Kumar Singh, Manish K. Chourasia, Kamal Dua, Sachin Kumar Singh, Santosh Kumar Guruen Limba Engleză Paperback – aug 2025
- Delves into the intricacies of delivering drugs in cancer precisely to designated sites through molecular recognition
- Provides in-depth coverage of existing market formulations, ongoing clinical trials, and intellectual property rights pertaining to targeted breast cancer therapies
- Offers researchers up-to-date insights into breast cancer targeting strategies
Preț: 826.14 lei
Preț vechi: 907.84 lei
-9% Nou
Puncte Express: 1239
Preț estimativ în valută:
158.22€ • 163.01$ • 132.54£
158.22€ • 163.01$ • 132.54£
Carte nepublicată încă
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780443333491
ISBN-10: 0443333491
Pagini: 320
Dimensiuni: 191 x 235 mm
Editura: ELSEVIER SCIENCE
ISBN-10: 0443333491
Pagini: 320
Dimensiuni: 191 x 235 mm
Editura: ELSEVIER SCIENCE
Cuprins
1. Chemotherapeutic Drugs and its side effects, Breast cancer biomarkers, Detection, Level of targeting and EPR effect
2. Receptor-Ligand based targeting approaches breast cancer.
3. Stimuli based targeting to breast cancer.
4. Advance strategies for targeting severe triple-negative breast cancer.
5. Targeted therapy for BRCA gene mutations breast cancer.
6. Androgen Receptor Targeted therapy for breast cancer
7. Monoclonal antibodies-based breast cancer targeting.
8. Breast cancer stem cell targeting.
9. HR+ Targeted Therapies
10. HER2-Positive (HER2+) & HER2-Negative (HER2−) Targeted Therapies
11. Immunotherapy for Breast Cancer
12. Current market formulation, therapy in clinical trials and status of IPR for Breast Cancer
2. Receptor-Ligand based targeting approaches breast cancer.
3. Stimuli based targeting to breast cancer.
4. Advance strategies for targeting severe triple-negative breast cancer.
5. Targeted therapy for BRCA gene mutations breast cancer.
6. Androgen Receptor Targeted therapy for breast cancer
7. Monoclonal antibodies-based breast cancer targeting.
8. Breast cancer stem cell targeting.
9. HR+ Targeted Therapies
10. HER2-Positive (HER2+) & HER2-Negative (HER2−) Targeted Therapies
11. Immunotherapy for Breast Cancer
12. Current market formulation, therapy in clinical trials and status of IPR for Breast Cancer